Medical Back Problems with Major Complication or Comorbidity: Inpatient Reimbursement Overview

DRG 551 addresses inpatient admissions for medical back problems complicated by a Major Complication or Comorbidity; it encompasses cases where additional serious conditions increase resource needs. This Diagnosis-Related Group matters because the presence of a Major Complication or Comorbidity elevates the reimbursement level to account for greater intensity of care and longer hospitalization.

Customize your policy alerts

Sign up for drg 551 policy alerts

Get alerted when payer policies referencing 551 are released or updated.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

DRG 551 Overview

DRG 551 covers hospital admissions for medical back problems where a Major Complication or Comorbidity is present, such as severe systemic illness or significant organ dysfunction that complicates management. Typical clinical presentations include acute exacerbations of chronic back pain, spinal infection, or neurologic compromise requiring intensified medical management. This Diagnosis-Related Group influences Medicare payment by reflecting higher resource use and longer lengths of stay when a Major Complication or Comorbidity is documented. Accurate clinical documentation and coding of the Major Complication or Comorbidity are central to proper inpatient reimbursement.

Explore openpayer tools

View all tools

Medical Back Problems with Major Complication or Comorbidity: Inpatient Reimbursement Overview

Customize your policy alerts

Sign up for drg 551 policy alerts

Get alerted when payer policies referencing 551 are released or updated.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

DRG 551 Overview

National Payment Rates

Across commercial payers the observed rate range runs from about $15K (BCBS minimum) up to $57K (Anthem maximum), with mean payer averages clustered between $15K and $27K. The widest spread is seen with Anthem, where values span from as low as $390 to $57K. See the table and chart below for payer-specific percentiles and distributions.

The CMS 2023 data represent national Medicare fee-for-service inpatient payments reported under the CMS Provider Utilization and Payment Data program. The table below shows average total payment ($15.2k), average submitted covered charges ($74.4k), average Medicare payment amount ($12.7k), and total discharges (14.5k). These figures summarize payments and volumes at the national level for Medicare FFS beneficiaries.

Average Total Payment	Average Submitted Charges	Average Medicare Payment	Total Discharges
$15K	$74K	$13K	14K

Patient Population

This DRG’s patient population skews toward Medicare-age beneficiaries rather than exclusively working-age adults, reflecting a primarily older adult cohort with notable representation in the Medicare population. Commercial payers (Cigna, Aetna, Anthem, BCBS) still cover a portion of cases, indicating a mixed but Medicare-leaning payer mix. Age distribution therefore trends older, with many patients in the Medicare-eligible age range.

State Payment Rates

State: Alaska1 / 49

Alaska Benchmarks

Alaska’s DRG 551 mean reimbursements span from $26K to $40K across payers, with Blue Cross Blue Shield and Anthem clustered at $26K and Cigna at $40K. The Cigna mean sits well above the other state payers and is a clear outlier versus local rates. Compared with national averages, Cigna’s Alaska mean is substantially higher while BCBS/Anthem are aligned below national payer means. See the table and chart below for the payer-level breakdown.

Key Insights for Alaska

Highest payer: Cigna (mean $40K); Lowest payers: Blue Cross Blue Shield and Anthem (both mean $26K).
Cigna’s mean reimbursement at $40K notably exceeds the other local payers and is meaningfully above national means for most payers, reflecting a higher regional rate for DRG 551 in Alaska.

Clinical Trials

Acute inpatient intervention trials evaluating multimodal pain control and early mobilization protocols for hospitalized patients with severe medical back problems complicated by major comorbid conditions (MCC), such as advanced cardiopulmonary disease or uncontrolled diabetes. These studies enroll medically complex, often older adults admitted for acute exacerbations of back pain or radiculopathy where comorbidities influence analgesic choices and mobility plans; outcomes measured include pain scores, opioid consumption, adverse events related to comorbidity interactions, and length of stay. Findings are relevant to providers for optimizing safe, effective inpatient care pathways and to payers for identifying protocols that reduce complications, readmissions, and resource use in a high-cost DRG population.
Comparative effectiveness trials comparing nonoperative inpatient therapies (e.g., targeted nerve interventions, image-guided injections, or structured physical therapy regimens) versus conservative medical management in patients with medical back problems who are poor surgical candidates due to MCC. These trials focus on subgroups with specific comorbid profiles—such as anticoagulation, chronic kidney disease, or severe cardiopulmonary illness—to determine which modalities yield the best functional recovery, pain reduction, and complication profiles during the index hospitalization and at short-term follow-up. The results inform clinicians on selecting interventions that balance efficacy and safety in complex patients and help payers evaluate which inpatient services provide the best value for this DRG.
Post-discharge outcomes and care coordination studies examining transitions from hospital to home or skilled nursing for patients with medical back problems and MCC, including interventions like comprehensive discharge planning, outpatient rehabilitation referral models, or remote monitoring to prevent readmission. These prospective cohort or pragmatic trials enroll patients with high comorbidity burden to assess 30- and 90-day readmissions, functional status, adherence to outpatient therapy, and total cost of care across settings. This research is crucial for providers and payers to identify strategies that improve long-term outcomes and reduce downstream utilization and costs associated with this medically complex DRG.

Single Level Combined Anterior and Posterior Spinal Fusion Except Cervical: Inpatient Reimbursement Overview

426-MULTIPLE-LEVEL-COMBINED-ANTERIOR-AND-POSTERIOR-SPINAL-FUSION-EXCEPT-CERVICAL-WITH-MCC-OR-CUSTOM-MADE-ANATOMICALLY-DESIGNED-INTERBODY-FUSION-DEVICE

Multiple Level Combined Anterior and Posterior Spinal Fusion Except Cervical with MCC or Custom-Made Anatomically Designed Interbody Fusion Device: Inpatient Reimbursement Overview

427-MULTIPLE-LEVEL-COMBINED-ANTERIOR-AND-POSTERIOR-SPINAL-FUSION-EXCEPT-CERVICAL-WITH-CC

Multiple Level Combined Anterior and Posterior Spinal Fusion Except Cervical with CC: Inpatient Reimbursement Overview

428-MULTIPLE-LEVEL-COMBINED-ANTERIOR-AND-POSTERIOR-SPINAL-FUSION-EXCEPT-CERVICAL-WITHOUT-CC-MCC

Multiple Level Combined Anterior and Posterior Spinal Fusion Except Cervical without CC/MCC: Inpatient Reimbursement Overview

429-COMBINED-ANTERIOR-AND-POSTERIOR-CERVICAL-SPINAL-FUSION-WITH-MCC

Combined Anterior and Posterior Cervical Spinal Fusion with MCC: Inpatient Reimbursement Overview

430-COMBINED-ANTERIOR-AND-POSTERIOR-CERVICAL-SPINAL-FUSION-WITHOUT-MCC

Combined Anterior and Posterior Cervical Spinal Fusion without MCC: Inpatient Reimbursement Overview

447-MULTIPLE-LEVEL-SPINAL-FUSION-EXCEPT-CERVICAL-WITH-MCC-OR-CUSTOM-MADE-ANATOMICALLY-DESIGNED-INTERBODY-FUSION-DEVICE

Multiple Level Spinal Fusion Except Cervical with MCC: Inpatient Reimbursement Overview

448-MULTIPLE-LEVEL-SPINAL-FUSION-EXCEPT-CERVICAL-WITHOUT-MCC

Multiple Level Spinal Fusion Except Cervical without MCC: Inpatient Reimbursement Overview

450-SINGLE-LEVEL-SPINAL-FUSION-EXCEPT-CERVICAL-WITH-MCC-OR-CUSTOM-MADE-ANATOMICALLY-DESIGNED-INTERBODY-FUSION-DEVICE

Single Level Spinal Fusion Except Cervical with MCC or Custom-Made Device: Inpatient Reimbursement Overview

451-SINGLE-LEVEL-SPINAL-FUSION-EXCEPT-CERVICAL-WITHOUT-MCC

Single Level Spinal Fusion Except Cervical without MCC: Inpatient Reimbursement Overview

Showing 1–10 of 104

References

1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.

Published by

Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Explore openpayer tools

View all tools

OpenPayer

Medical Back Problems with Major Complication or Comorbidity: Inpatient Reimbursement Overview

Sign up for drg 551 policy alerts

DRG 551 Overview

OpenPayer

Medical Back Problems with Major Complication or Comorbidity: Inpatient Reimbursement Overview

Sign up for drg 551 policy alerts

DRG 551 Overview

National Payment Rates

Patient Population

State Payment Rates

Alaska Benchmarks

Key Insights for Alaska

Clinical Trials

Related Codes

References

National Payment Rates

Patient Population

State Payment Rates

Alaska Benchmarks

Key Insights for Alaska

Clinical Trials

Related Codes

References